|
83
|
306
|
7ldlA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
80
|
306
|
7lcsA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
86
|
299
|
7k0eA |
1.90 a resolution structure of sars-cov-2 3cl protease in complex with deuterated gc376 |
|
89
|
305
|
7aehA |
Sars-cov-2 main protease in a covalent complex with a pyridine derivative of abt-957, compound 1 |
|
89
|
305
|
7aegA |
Sars-cov-2 main protease in a covalent complex with sdz 224015 derivative, compound 5 |
|
85
|
305
|
7m91A |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 25 |
|
86
|
301
|
7m8mA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 11 |
|
82
|
301
|
7m8zA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 29 |
|
85
|
302
|
7m8xA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 6 |
|
77
|
305
|
7m90A |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 50 |
|
84
|
306
|
7n8cA |
Joint x-ray/neutron structure of sars-cov-2 main protease (mpro) in complex with mcule5948770040 |
|
82
|
301
|
7mgrA |
Sars-cov-2 main protease in complex with nsp8/9 substrate peptide |
|
88
|
306
|
7m8yA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 15 |
|
87
|
305
|
7mgsA |
Sars-cov-2 main protease in complex with n-terminal autoprocessing substrate |
|
85
|
301
|
7m8oA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 19 |
|
82
|
306
|
7n89A |
Room-temperature x-ray structure of sars-cov-2 main protease c145a mutant in complex with substrate ac-savlqsgf-conh2 |
|
85
|
301
|
7m8nA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 16 |
|
89
|
295
|
7nh7A |
Oc43 coronavirus methyltransferase |
|
84
|
301
|
7m8pA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 23 |
|
92
|
306
|
7cuuA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with mg132 |
|
85
|
305
|
7e19A |
Crystal structure of sar-cov-2 3cl protease complex with inhibitor sh-5 |
|
84
|
303
|
7e18A |
Crystal structure of sar-cov-2 3cl protease complex with inhibitor yh-53 |
|
80
|
301
|
7cutA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with z-vad-fmk |
|
91
|
306
|
7n5zA |
Sars-cov-2 main protease c145s mutant |
|
81
|
306
|
7n6nA |
Sars-cov-2 main protease c145s mutant in complex with n and c-terminal residues |
|
85
|
346
|
7n33A |
Sars-cov-2 nsp15 endoribonuclease pre-cleavage state |
|
89
|
348
|
5sahA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with en300-100112 |
|
94
|
348
|
5sa4A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z239136710 |
|
90
|
348
|
5saiA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z1424343998 |
|
92
|
348
|
5sa8A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z68299550 |
|
92
|
348
|
5saaA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z319891284 |
|
91
|
348
|
5safA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with en300-321461 |
|
89
|
348
|
5sabA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z31504642 |
|
23
|
116
|
7eq4A |
Crystal structure of the n-terminus of nonstructural protein 1 from sars-cov-2 |
|
90
|
348
|
5saeA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z3219959731 |
|
92
|
348
|
5sacA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z59181945 |
|
91
|
348
|
5sa5A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z1530301542 |
|
88
|
348
|
5sa6A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z2856434783 |
|
92
|
348
|
5sa9A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z2697514548 |
|
90
|
348
|
5sa7A |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z1673618163 |
|
90
|
348
|
5sagA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with en300-1605072 |
|
91
|
348
|
5sadA |
Pandda analysis group deposition -- crystal structure of sars-cov-2 nendou in complex with z425449682 |
|
86
|
306
|
7bajA |
Crystal structure of ligand-free sars-cov-2 main protease |
|
4
|
70
|
7eno4 |
Mutant strain m3 of foot-and-mouth disease virus type o |
|
91
|
300
|
7balA |
Crystal structure of sars-cov-2 main protease treated with ebselen derivative of mr6-31-2 |
|
87
|
304
|
7bakA |
Crystal structure of sars-cov-2 main protease treated with ebselen |
|
2
|
71
|
7enp4 |
Wild type of o type foot-and-mouth disease virus |
|
182
|
635
|
7mswA |
Full length sars-cov-2 nsp2 |
|
157
|
502
|
7msxA |
Sars-cov-2 nsp2 |
|
30
|
200
|
7nul1 |
Rhinovirus-14 icam-1 activated particle at ph 6.2 |
